<!DOCTYPE html>
<html lang="en-us">
  <head>
	<meta name="generator" content="Hugo 0.85.0" />
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>fallingstar-Daily-rss | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>fallingstar-Daily-rss</span>
        <span>2024-05-24</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38784019/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240524184553&amp;v=2.18.0.post9&#43;e462414">Automated 3D cytoplasm segmentation in soft X-ray tomography</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38784019-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240524184553-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Cells' structure is key to understanding cellular function, diagnostics, and therapy development. Soft X-ray tomography (SXT) is a unique tool to image cellular structure without fixation or labeling at high spatial resolution and throughput. Fast acquisition times increase demand for accelerated image analysis, like segmentation. Currently, segmenting cellular structures is done manually and is a major bottleneck in the SXT data analysis. This paper introduces ACSeg, an automated 3D &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38784161/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240524184553&amp;v=2.18.0.post9&#43;e462414">Examining childhood experiences and personality functioning as potential predictors for the speed of recovery during psychotherapy of patients with anxiety disorders</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38784161-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240524184553-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Among patients with anxiety disorders, adverse childhood experiences lead to a lower speed of recovery during psychotherapy. Therefore, childhood adversity should be routinely assessed before and thoroughly addressed during psychotherapy in patients with anxiety &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38784234/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240524184553&amp;v=2.18.0.post9&#43;e462414">Exploring the gap: attitudes, knowledge, and training needs in complementary and integrative medicine among healthcare professionals at German university hospitals</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38784234-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240524184553-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    INTRODUCTION: The use of Complementary and Integrative Medicine (CIM) is very popular among the general population in Germany. However, international studies show that nurses, physicians, and other health care professionals (HCPs) at hospitals often do not feel sufficiently informed about different CIM approaches. Moreover, they do not feel trained enough to counsel their patients appropriately. In the German-speaking context, particularly within university hospitals, research on this subject &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38784248/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240524184553&amp;v=2.18.0.post9&#43;e462414">The relationship between health literacy and health-seeking behavior amongst university students in Ghana: A cross-sectional study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38784248-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240524184553-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Findings support the crucial role of health literacy in timely hospital visits by patients. This implies the need to improve health literacy through education, policy, and research. This can promote prevention of diseases through timely health-seeking and improve preparedness against health crises. The study suggests health literacy should be integrated into educational curricula and regular health campaigns run by public health &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38784899/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240524184553&amp;v=2.18.0.post9&#43;e462414">Vertebral artery hypoplasia and hemodynamic impairment in transient global amnesia: a case control study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38784899-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240524184553-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    INTRODUCTION: The aetiology of transient global amnesia (TGA) is still a matter of debate. Besides ischemia of the mesial temporal lobe including the hippocampus, migraine-like mechanisms, epileptic seizures affecting mnestic structures, or venous congestion in the (para) hippocampal area due to jugular vein insufficiency have been discussed. We assessed the diameters of the intracranial arteries of TGA patients compared to controls to identify differences that support the hypothesis of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38785043/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240524184553&amp;v=2.18.0.post9&#43;e462414">Porocarcinomas with PAK1/2/3 fusions: a series of 12 cases</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38785043-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240524184553-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Our study suggests that PAK1/2/3 fusions is the oncogenic driver of a subset of porocarcinomas lacking YAP1 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38785069/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240524184553&amp;v=2.18.0.post9&#43;e462414">Type II &amp;amp; III inhibitors of tropomyosin receptor kinase (Trk): a 2020-2022 patent update</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38785069-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240524184553-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    INTRODUCTION: The Trk family proteins are membrane-bound kinases predominantly expressed in neuronal tissues. Activated by neurotrophins, they regulate critical cellular processes through downstream signaling pathways. Dysregulation of Trk signaling can drive a range of diseases, making the design and study of Trk inhibitors a vital area of research. This review explores recent advances in the development of type II and III Trk inhibitors, with implications for various therapeutic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38785181/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240524184553&amp;v=2.18.0.post9&#43;e462414">The impact of the route to diagnosis in nephroblastoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38785181-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240524184553-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The route to diagnosis of WT correlates with age, general health status, tumor volume, and stage distribution, but does not impact the outcome of patients. Nonetheless, diagnosis without tumor related symptoms results in lower treatment burden and thus improved quality of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38785209/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240524184552&amp;v=2.18.0.post9&#43;e462414">Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38785209-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240524184552-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Semaglutide reduced the risk of clinically important kidney outcomes and death from cardiovascular causes in patients with type 2 diabetes and chronic kidney disease. (Funded by Novo Nordisk; FLOW ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38785284/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240524184553&amp;v=2.18.0.post9&#43;e462414">Dense-sparse quantum Monte Carlo algebraic diagrammatic construction and importance ranking</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38785284-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240524184553-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Quantum Monte Carlo Algebraic Diagrammatic Construction (QMCADC) has been proposed as a reformulation of the second-order ADC scheme for the polarization propagator within the projection quantum Monte Carlo formalism. Dense-sparse partitioning and importance ranking filtering strategies are now exploited to accelerate its convergence and to alleviate the sign problem inherent in such calculations. By splitting the configuration space into dense and sparse subsets, the corresponding &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38785313/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240524184552&amp;v=2.18.0.post9&#43;e462414">Cow&#39;s Milk Containing Avian Influenza A(H5N1) Virus - Heat Inactivation and Infectivity in Mice</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38785313-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240524184552-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38785458/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240524184553&amp;v=2.18.0.post9&#43;e462414">12-Month Trajectories of Health-Related Quality of Life Following Hospitalization in German Cancer Centers-A Secondary Data Analysis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38785458-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240524184553-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Patient-reported outcomes (PROs) offer a diverse array of potential applications within medical research and clinical practice. In comparative research, they can serve as tools for delineating the trajectories of health-related quality of life (HRQoL) across various cancer types. We undertook a secondary data analysis of a cohort of 1498 hospitalized cancer patients from 13 German cancer centers. We assessed the Physical and Mental Component Scores (PCS and MCS) of the 12-Item Short-Form &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38785922/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240524184553&amp;v=2.18.0.post9&#43;e462414">Fundus Autofluorescence in Posterior and Panuveitis-An Under-Estimated Imaging Technique: A Review and Case Series</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38785922-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240524184553-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Fundus autofluorescence (FAF) is a prompt and non-invasive imaging modality helpful in detecting pathological abnormalities within the retina and the choroid. This narrative review and case series provides an overview on the current application of FAF in posterior and panuveitis. The literature was reviewed for articles on lesion characteristics on FAF of specific posterior and panuveitis entities as well as benefits and limitations of FAF for diagnosing and monitoring disease. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38786100/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240524184553&amp;v=2.18.0.post9&#43;e462414">Pre-Clinical Assessment of SAR442257, a CD38/CD3xCD28 Trispecific T Cell Engager in Treatment of Relapsed/Refractory Multiple Myeloma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38786100-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240524184553-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Current treatment strategies for multiple myeloma (MM) are highly effective, but most patients develop relapsed/refractory disease (RRMM). The anti-CD38/CD3xCD28 trispecific antibody SAR442257 targets CD38 and CD28 on MM cells and co-stimulates CD3 and CD28 on T cells (TCs). We evaluated different key aspects such as MM cells and T cells avidity interaction, tumor killing, and biomarkers for drug potency in three distinct cohorts of RRMM patients. We found that a significantly higher &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38786168/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240524184553&amp;v=2.18.0.post9&#43;e462414">One- vs. Two-Stage Revision for Periprosthetic Shoulder Infections: A Systematic Review and Meta-Analysis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38786168-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240524184553-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Periprosthetic shoulder infection (PSI) remains a challenging complication after shoulder arthroplasty. Therapeutic options include one- or two-stage revision, irrigation and debridement, and resection arthroplasty. With our systematic review and meta-analysis, we aimed to compare one- and two-stage revisions for periprosthetic shoulder joint infections and determine the most appropriate therapeutic procedure. We performed an extensive literature search in PubMed, Ovid Medline, Cochrane &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38786317/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240524184553&amp;v=2.18.0.post9&#43;e462414">Cranial Computer Tomography with Photon Counting and Energy-Integrated Detectors: Objective Comparison in the Same Patients</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38786317-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240524184553-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    This study provides an objective comparison of cranial computed tomography (CT) imaging quality and radiation dose between photon counting detectors (PCCTs) and energy-integrated detectors (EIDs). We retrospectively analyzed 158 CT scans from 76 patients, employing both detector types on the same individuals to ensure a consistent comparison. Our analysis focused on the Computed Tomography Dose Index and the Dose-Length Product together with the contrast-to-noise ratio and the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38786349/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240524184553&amp;v=2.18.0.post9&#43;e462414">The Value of Contrast-Enhanced Ultrasound (CEUS) in the Evaluation of Central Lung Cancer with Obstructive Atelectasis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38786349-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240524184553-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Purpose: To assess the diagnostic performance of contrast-enhanced ultrasound (CEUS) alongside contrast-enhanced computed tomography (CECT) in evaluating central lung cancer (CLC). Materials and Methods: From 2006 to 2022, 54 patients with CLC and obstructive atelectasis (OAT) underwent standardized examinations using CEUS in addition to CECT. The ability to differentiate CLC from atelectatic tissue in CECT and CEUS was categorized as distinguishable or indistinguishable. In CEUS, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38786402/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240524184553&amp;v=2.18.0.post9&#43;e462414">Value-Based Health Care for Prostate Cancer Centers by Implementing Specific Key Performance Indicators Using a Balanced Score Card</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38786402-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240524184553-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The developed BSC provides a comprehensive set of perspectives for an Integrated Practice Unit or center in PC care, ensuring that the indicators remain manageable and applicable. The BSC facilitates value creation in line with Porter&rsquo;s Full Cycle of Care by systematically collecting and providing economic, personnel, and medical results, actions, and indicators. In particular, this BSC includes KPIs of structured training of practitioners and metrics of the German Cancer &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38787010/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240524184553&amp;v=2.18.0.post9&#43;e462414">Advanced Imaging of Shunt Valves in Cranial CT Scans with Photon-Counting Scanner</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38787010-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240524184553-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    This brief report aimed to show the utility of photon-counting technology alongside standard cranial imaging protocols for visualizing shunt valves in a patient&rsquo;s cranial computed tomography scan. Photon-counting CT scans with cranial protocols were retrospectively surveyed and four types of shunt valves were encountered: proGAV 2.0^(®), M.blue^(®), Codman Certas^(®), and proSA^(®). These scans were compared with those obtained from non-photon-counting scanners at different time points for &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38787721/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240524184553&amp;v=2.18.0.post9&#43;e462414">Hunger and satiety: Neuronal dynamics in Hydra behavior</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38787721-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240524184553-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Hormonal and neuronal inputs to the brain control how much animals eat. The origins of this behavior were unclear, but in this issue of Cell Reports, Giez et al.¹ describe specific neurons inhibiting feeding in evolutionary ancient animals without &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38787726/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240524184553&amp;v=2.18.0.post9&#43;e462414">Dark force rising: Reawakening and targeting of fetal-like stem cells in colorectal cancer</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38787726-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240524184553-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Stem cells play pivotal roles in maintaining intestinal homeostasis, orchestrating regeneration, and in key steps of colorectal cancer (CRC) initiation and progression. Intriguingly, adult stem cells are reduced during many of these processes. On the contrary, primitive fetal programs, commonly detected in development, emerge during tissue repair, CRC metastasis, and therapy resistance. Recent findings indicate a dynamic continuum between adult and fetal stem cell programs. We discuss &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38787836/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240524184553&amp;v=2.18.0.post9&#43;e462414">Optimal timing of a colonoscopy screening schedule depends on adenoma detection, adenoma risk, adherence to screening and the screening objective: A microsimulation study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-24</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38787836-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240524184553-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Colonoscopy-based screening provides protection against colorectal cancer (CRC), but the optimal starting age and time intervals of screening colonoscopies are unknown. We aimed to determine an optimal screening schedule for the US population and its dependencies on the objective of screening (life years gained or incidence, mortality, or cost reduction) and the setting in which screening is performed. We used our established open-source microsimulation model CMOST to calculate &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38778718/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240523183437&amp;v=2.18.0.post9&#43;e462414">Associations between tobacco smoking status and patch test results-A cross-sectional pilot study from the Information Network of Departments of Dermatology (IVDK)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38778718-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240523183437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Although our study does not allow a firm conclusion on whether smoking status contributes to certain contact sensitizations, it confirms an association of smoking with hand dermatitis and occupational &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38778793/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240523183437&amp;v=2.18.0.post9&#43;e462414">Early Access to First-Seizure Clinics, Subsequent Outcomes, and Factors Associated With Attendance</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38778793-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240523183437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS AND RELEVANCE: Results of this cohort study suggest that FSC attendance, particularly early attendance, was associated with reduced rates of subsequent hospital utilization. This knowledge may support adequately resourcing FSCs to improve equitable, timely access. Future study directions include assessing interventions that may support FSC attendance for at-risk &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38779395/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240523183437&amp;v=2.18.0.post9&#43;e462414">Evaluation of Different Patterns of Zygomaticoorbital Complex Fractures</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38779395-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240523183437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: According to the results, knowledge of the fracture pattern variability of the ZMO complex could in certain circumstances designate CT or CBCT as mandatory before operating on ZMO fractures. Consequently, unnecessary incisions could be avoided. The high concomitance of paranasal buttress fracture also suggests its intraoperative surgical exploration. Further studies should correlate the clinical findings with indication for surgery and postoperative outcome for the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38779691/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240523183437&amp;v=2.18.0.post9&#43;e462414">A case of severe side effects to androgen receptor inhibitor and consequently switch to radioligand therapy in early castration resistant prostate cancer</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38779691-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240523183437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The development of potent novel androgen receptor inhibitors (ARi) such as apalutamide have improved the life expectancy in men with castration-resistant prostate cancer (CRPCa). However, some serious toxicity can occur limiting the choice of treatment in CRPCa. In our case, the patient experienced severe toxicity after initiation of apalutamide. Diagnostic PSMA-PET/CT confirmed the recurrence and tailored the treatment with ^(177)Lu-PSMA-617 (RLT), a beta emitter radionuclide. RLT resulted &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38779695/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240523183437&amp;v=2.18.0.post9&#43;e462414">What do the teachers want? A targeted needs assessment survey for prospective didactic training of psychiatry medical educators</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38779695-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240523183437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The majority of physicians and psychologists at psychiatric university hospitals considered professional development for faculty to be helpful for teaching medical students. Bedside teaching and error culture management were the most desired teaching topics for training medical teachers. Tailored educational interventions are recommended, with target-oriented priorities for different hierarchical &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38779910/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240523183437&amp;v=2.18.0.post9&#43;e462414">PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38779910-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240523183437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: European collaboration can facilitate the implementation of PCM and thereby provide affordable and equitable access to precision diagnostics and matched therapies for more patients. ble from the PCM4EU website (<a href="http://www.pcm4eu.eu">http://www.pcm4eu.eu</a>). The first reports, including an overview of requirements for the reimbursement systems in participating countries and a guide on patient involvement, are expected to be published in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780378/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240523183433&amp;v=2.18.0.post9&#43;e462414">Audio Interview: Preparing for a Possible Avian Influenza Outbreak</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780378-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240523183433-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780378/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240524184552&amp;v=2.18.0.post9&#43;e462414">Audio Interview: Preparing for a Possible Avian Influenza Outbreak</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780378-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240524184552-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780548/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240523183437&amp;v=2.18.0.post9&#43;e462414">State and trait characteristics of attachment as predictors of outcome in inpatient psychotherapy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780548-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240523183437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Attachment has mostly been investigated as a stable characteristic of individuals, although theoretical considerations and recent empirical findings suggest that attachment styles are also subject to change. When attachment is investigated as a treatment factor in psychotherapy, state and trait characteristics need to be differentiated, as they warrant different conclusions. This study examined the trait- and statelike characteristics of attachment styles over the course of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780712/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240523183437&amp;v=2.18.0.post9&#43;e462414">Prognostic relevance of global work index and global constructive work in patients with non-ischemic dilated cardiomyopathy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780712-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240523183437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Myocardial work (MW) derived from pressure-strain loops is a novel non-invasive tool to assess left ventricular (LV) function, incorporating global longitudinal strain (GLS) by speckle tracking echocardiography and non-invasively assessed blood pressure. Studies on the role of MW in dilated cardiomyopathy (DCM) are still limited. Therefore, the aim of this study was to evaluate the potential value of MW for predicting adverse outcomes in patients with DCM. 116 consecutive patients with DCM &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780804/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240523183437&amp;v=2.18.0.post9&#43;e462414">MAGnetic REtriaval device for minimally invasive Ureter Stent removal (MAGREUS)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780804-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240523183437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Purpose To assess the effectiveness and pain intensity associated with magnetic ureteric stent removal using a retriever, without the aid of ultrasound guidance. Methods We prospectively enrolled 100 patients who underwent retrograde rigid/flexible ureterorenoscopy with or without laser lithotripsy for ureteronephrolithiasis treatment from September 2021 to June 2023. These patients were assigned in two groups. Group 1 underwent the traditional ureteric stent insertion, while Group 2 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780812/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240523183437&amp;v=2.18.0.post9&#43;e462414">Correction: Commentary of the SKLM to the EFSA opinion on risk assessment of N-nitrosamines in food</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780812-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240523183437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780837/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240523183437&amp;v=2.18.0.post9&#43;e462414">Prevention at home in older persons with (pre-)frailty: analysis of participants&#39; recruitment and characteristics of the randomized controlled PromeTheus trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780837-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240523183437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Different strategies may be required to successfully recruit (pre-)frail home-living older adults into preventive programs. Direct recruitment strategies, in which potential participants are directly informed about the prevention program, seem to be more promising than GP recruitment but may result in enrolment of persons with less functional impairment and higher recruitment &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780917/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240523183435&amp;v=2.18.0.post9&#43;e462414">SMACing down relapsed T-ALL</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780917-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240523183435-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780917/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240524184552&amp;v=2.18.0.post9&#43;e462414">SMACing down relapsed T-ALL</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780917-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240524184552-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780918/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240523183435&amp;v=2.18.0.post9&#43;e462414">VEXAS syndrome: from a vascular perspective</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780918-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240523183435-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780918/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240524184552&amp;v=2.18.0.post9&#43;e462414">VEXAS syndrome: from a vascular perspective</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780918-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240524184552-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780919/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240523183435&amp;v=2.18.0.post9&#43;e462414">The stepbrothers of ABLSON have their own sensitivity</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780919-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240523183435-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780919/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240524184552&amp;v=2.18.0.post9&#43;e462414">The stepbrothers of ABLSON have their own sensitivity</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780919-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240524184552-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780920/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240523183435&amp;v=2.18.0.post9&#43;e462414">Oxygen tug-of-war, voxelotor, and the brain</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780920-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240523183435-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780920/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240524184552&amp;v=2.18.0.post9&#43;e462414">Oxygen tug-of-war, voxelotor, and the brain</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780920-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240524184552-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780921/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240523183435&amp;v=2.18.0.post9&#43;e462414">&#34;Ring-form&#34; megakaryocytic dysplasia in STAG2-mutated myelodysplastic neoplasm</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780921-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240523183435-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780921/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240524184552&amp;v=2.18.0.post9&#43;e462414">&#34;Ring-form&#34; megakaryocytic dysplasia in STAG2-mutated myelodysplastic neoplasm</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780921-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240524184552-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780922/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240523183435&amp;v=2.18.0.post9&#43;e462414">Giving T-cell bispecifics a helping hand</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780922-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240523183435-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780922/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240524184552&amp;v=2.18.0.post9&#43;e462414">Giving T-cell bispecifics a helping hand</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780922-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240524184552-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780923/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240523183435&amp;v=2.18.0.post9&#43;e462414">Conditioning for alloengraftment in FA</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780923-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240523183435-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780923/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240524184552&amp;v=2.18.0.post9&#43;e462414">Conditioning for alloengraftment in FA</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780923-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240524184552-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780924/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240523183435&amp;v=2.18.0.post9&#43;e462414">Biclonal mantle cell lymphoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780924-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240523183435-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780924/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240524184552&amp;v=2.18.0.post9&#43;e462414">Biclonal mantle cell lymphoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780924-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240524184552-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38781562/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240524184552&amp;v=2.18.0.post9&#43;e462414">IL-1 in Aging and Pathologies of Hematopoietic Stem Cells</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38781562-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240524184552-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Defense-oriented inflammatory reactivity supports survival at younger age, but might contribute to health impairments in modern, aging societies. The IL-1 cytokines are highly conserved and regulated, pleiotropic mediators of inflammation, essential to respond adequately to infection and tissue damage, but also with potential host damaging effects when left unresolved. In this review, we discuss how continuous low-level IL-1 signaling contributes to aging-associated hematopoietic stem &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38781564/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240524184552&amp;v=2.18.0.post9&#43;e462414">Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37&#43; lymphoid malignancies</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38781564-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240524184552-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    We report on the first-in-human clinical trial using chimeric antigen receptor (CAR) T-cells targeting CD37, an antigen highly expressed in B- and T-cell malignancies (clinicaltrials.gov NCT04136275). Five patients with relapsed or refractory CD37+ lymphoid malignancies were enrolled and infused with autologous CAR-37 T-cells. CAR-37 T-cells expanded in the peripheral blood of all patients and, at peak, comprised &gt;94% of the total lymphocytes in 4/5 patients. Tumor responses were observed in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38782966/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1jUKNaekwK5-jhnLOsYRQeEvu-lGfd382Ao3uOl7PziqjjxYZK&amp;fc=20220919201732&amp;ff=20240524181559&amp;v=2.18.0.post9&#43;e462414">COVID-19 was associated with the complications after allogeneic hematopoietic stem cell transplantation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38782966-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1juknaekwk5-jhnlosyrqeevu-lgfd382ao3uol7pziqjjxyzk-fc-20220919201732-ff-20240524181559-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    We aimed to identify the severity and duration of COVID-19 infection on complications after allo-HSCT. Enrolled 179 hospitalized patients with COVID-19 were categorized into long-term infection (&gt; 18 days, n = 90) or short-term infection group (≤ 18 days, n = 89) according to the median duration of COVID-19. The severity of COVID-19 was categorized as asymptomatic infection, mild, moderate, severe, and critical illness according to guidelines of National Institutes of Health. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfFBG0EL3">🔻有个很简单的道理，但是也可以讲一下：🔻世界的运行是客观的，事物的发展是客观的，事业的前进也是客观的，对于事业的成效，并不是所有人都能理解，从中国...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-offbg0el3/">
    
    
    
    
    
      
    
    🔻有个很简单的道理，但是也可以讲一下：<!-- raw HTML omitted -->🔻世界的运行是客观的，事物的发展是客观的，事业的前进也是客观的，对于事业的成效，并不是所有人都能理解，从中国革命的一开始，“这么做有什么用”的疑问就一直存在。<!-- raw HTML omitted -->🔻教员同志曾经说：“中国这个客观世界，整个地说来，是由中国人认识的，不是在共产国际管中国问题的同志们认识的。共产国际的这些同志就不了解或者说不很了解中国社会，中 国 民 族，中 国 革 命。对于中国这个客观世界，我们自己在很长时间内都认识不清楚，何况外国同志呢？”<!-- raw HTML omitted -->🔻 我们的实践证明：感觉到了的东西，我们不能立刻理解它，只有理解了的东西才更深刻地感觉它。感觉只解决现象问题，理论才解决本质问题。这 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfFI7AeGb">对[裂开]//@关于脆脆鲨:就是那个偷2000吨钢筋的？ - 转发 @包容万物恒河水:&amp;ensp;🔻第235卫戍区军事法庭称，辩方对涉嫌欺诈的前58集团军司令伊万·波波夫少将...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-offi7aegb/">
    
    
    
    
    
      
    
    对<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->//<!-- raw HTML omitted -->@关于脆脆鲨<!-- raw HTML omitted -->:就是那个偷2000吨钢筋的？<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻第235卫戍区军事法庭称，辩方对涉嫌欺诈的前58集团军司令伊万·波波夫少将的拘留提出上诉。正如律师谢尔盖·布伊诺夫斯基告诉塔斯社的那样，他不承认犯有任何非法行为。<!-- raw HTML omitted -->🔻目前，俄罗斯侦查委员会要求释放被拘留的波波夫将军，以监 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfFJ8DfJu">🔻家人们，我今天看到一个在英伟达重大财报发布前做空的。🔻它吊不吊？ [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-offj8dfju/">
    
    
    
    
    
      
    
    🔻家人们，我今天看到一个在英伟达重大财报发布前做空的。<!-- raw HTML omitted -->🔻它吊不吊？ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfFJYof68">反正他现在背的罪名是：“盗卖了1700吨扎波罗热作为人道主义物资捐来的金属”。//@这个名称好low啊:他偷那么多钢筋转手卖了？还是干啥了//@包容万物恒河水:对[裂...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-offjyof68/">
    
    
    
    
    
      
    
    反正他现在背的罪名是：“盗卖了1700吨扎波罗热作为人道主义物资捐来的金属”。//<!-- raw HTML omitted -->@这个名称好low啊<!-- raw HTML omitted -->:他偷那么多钢筋转手卖了？还是干啥了//<!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->:对<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->//&lt;a href=&ldquo;<a href="https://weibo.com/n/%E5%258">https://weibo.com/n/%E5%8</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfFmWrpFD">🔻曼谷医院官员说，在新加坡航空公司湍流航班上仍在接受治疗的 40 人中，22 人脊椎受伤，6 人脑部和颅骨受伤。🔻via Al Jazeera 网站🔻…… [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-offmwrpfd/">
    
    
    
    
    
      
    
    🔻曼谷医院官员说，在新加坡航空公司湍流航班上仍在接受治疗的 40 人中，22 人脊椎受伤，6 人脑部和颅骨受伤。<!-- raw HTML omitted -->🔻via Al Jazeera 网站<!-- raw HTML omitted -->🔻…… <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfFnxvk1V">你这个地下室正经吗？ - 转发 @包容万物恒河水:&amp;ensp;🔻卡德罗夫说：“我有一个梦想——把泽连斯基安置在我们车臣的地下室里。”🔻via RT官网🔻[哆啦A梦害...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-offnxvk1v/">
    
    
    
    
    
      
    
    你这个地下室正经吗？<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻卡德罗夫说：“我有一个梦想——把泽连斯基安置在我们车臣的地下室里。”<!-- raw HTML omitted -->🔻via RT官网<!-- raw HTML omitted -->🔻<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->？ <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_video_default.png%22">https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_video_default.png&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfFoVxVaS">🔻俄军第 27 师的炮兵用 D-30 榴弹炮命中了一辆 M1。🔻D-30 的炮弹好像几百美元一发？🔻via vk/RVV [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-offovxvas/">
    
    
    
    
    
      
    
    🔻俄军第 27 师的炮兵用 D-30 榴弹炮命中了一辆 M1。<!-- raw HTML omitted -->🔻D-30 的炮弹好像几百美元一发？<!-- raw HTML omitted -->🔻via vk/RVV <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/4brZXn6Llx08f5wpDcRy010412001cxh0E010.mp4?label=mp4_hd&amp;amp;template=848x464.25.0&amp;amp;ori=0&amp;amp;ps=1Cx9YB1mmR49jS&amp;amp;Expires=1716505909&amp;amp;ssig=XGZMBjsqJe&amp;am">https://f.video.weibocdn.com/o0/4brZXn6Llx08f5wpDcRy010412001cxh0E010.mp4?label=mp4_hd&amp;amp;template=848x464.25.0&amp;amp;ori=0&amp;amp;ps=1Cx9YB1mmR49jS&amp;amp;Expires=1716505909&amp;amp;ssig=XGZMBjsqJe&amp;am</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfFqImzMd">🔻“统一套餐”先放一边。🔻细说为什么加班？#中国台湾937舰这里是中国管辖海域# [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-offqimzmd/">
    
    
    
    
    
      
    
    🔻“统一套餐”先放一边。<!-- raw HTML omitted -->🔻细说为什么加班？<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#中国台湾937舰这里是中国管辖海域#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/639b1bfbly1hpzvt75svvj20hx0qtdsi.jpg%22">https://tvax4.sinaimg.cn/large/639b1bfbly1hpzvt75svvj20hx0qtdsi.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfFr7sr2D">🔻？ [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-offr7sr2d/">
    
    
    
    
    
      
    
    🔻？ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfFssbIIa">🔻我知道这个视频是AI换脸。🔻但是，这个视频流传极其广，我怀疑卡德罗夫是不是看了这个视频才说出“想把他安置在车臣地下室”这句话？ [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-offssbiia/">
    
    
    
    
    
      
    
    🔻我知道这个视频是AI换脸。<!-- raw HTML omitted -->🔻但是，这个视频流传极其广，我怀疑卡德罗夫是不是看了这个视频才说出“想把他安置在车臣地下室”这句话？ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/D0Eumk1Glx08f5x0Fyly010412004QaV0E010.mp4?label=mp4_hd&amp;amp;template=360x638.24.0&amp;amp;ori=0&amp;amp;ps=1Cx9YB1mmR49jS&amp;amp;Expires=1716505909&amp;amp;ssi">https://f.video.weibocdn.com/o0/D0Eumk1Glx08f5x0Fyly010412004QaV0E010.mp4?label=mp4_hd&amp;amp;template=360x638.24.0&amp;amp;ori=0&amp;amp;ps=1Cx9YB1mmR49jS&amp;amp;Expires=1716505909&amp;amp;ssi</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OfCUK47GM">久保史绪里#久保史绪里手机博# 2024.05.19 13:34(补)「哈…」昨天的服装太可爱啦…来看看… [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ofcuk47gm/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OfCZxrBDG">久保史绪里#久保史绪里手机博# 2024.05.19 13:34「长」大家好早上开始就反复播放『Mela!』。昨天是开心得开心得难以忘记的时光甚至会想是不是在做梦。呼呼呼。今...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ofczxrbdg/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%259">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OfD96Blzr">久保史绪里#久保史绪里手机博# 2024.05.20 10:38(补)「哦！」早上好〜今天也继续努力吧今天呢，是要将思考的各种东西认真积极地推进的日子。没有什么特别的意思...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ofd96blzr/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OfD9Jk20c">久保史绪里#久保史绪里手机博# 2024.05.22 12:43(补)「歌」大家好今天也鼓足干劲努力吧我要做的事已经堆积如山了努力吧逐一解决吧好嘞</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ofd9jk20c/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp;isnewpage=1%22">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp;isnewpage=1&quot;</a>  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OfD9x15b4">久保史绪里#久保史绪里手机博# 2024.05.20 17:48(补)「要看哦」今天19点开始（JST）是nogiobi哦！！要看哦！是nogiobi哦！！！！！要看哦！因为是重要的事所以说...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ofd9x15b4/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;am">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;am</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OfE6QcIkE">久保史绪里 - 转发 @乃木坂46:&amp;ensp;📸#乃木坂46GALLERY#📸💜Works💜乃木坂46 [图片][图片][图片][图片][图片][图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ofe6qcike/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@乃木坂46<!-- raw HTML omitted -->: 📸&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%83%E6%9C%A8%E5%9D%8246GALLERY%252">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%83%E6%9C%A8%E5%9D%8246GALLERY%2</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1iH4y1u7fD">陈翔六点半：愿你我与温暖不期而遇</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1ih4y1u7fd/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.npr.org/2024/05/23/1198908837/throughline-philippines">Mythos and Melodrama in the Philippines (Throwback)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/www-npr-org-2024-05-23-1198908837-throughline-philippines/">
    
    
    
    
    
      
    
    Welcome to the &ldquo;Epic of Marcos.&rdquo; In this tale of a family that&rsquo;s larger than life, Ferdinand Marcos, the former dictator of the Philippines, is at the center. But the figures that surround him are just as important: Imelda, his wife and muse; Bongbong, his heir; and the United States, his faithful sidekick. The story of the Marcos family is a blueprint for authoritarianism, laying out clearly how melodrama, paranoia, love, betrayal and a hunger for power collide to create a myth capable of propelling a nation. Today on the show, the rise, fall, and resurrection of a dynasty — and what that &hellip;
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

